This week, Parul Oza is back on SpeakPharma to take us through the changes the global pharmaceutical supply chain is experiencing as a result of the Covid-19 pandemic. This time, the managing director of the Ahmedabad (India) headquartered complete outsourcing solutions provider talks about the strengths of the Indian pharmaceutical industry and how it can capitalize on the opportunities emerging in the post-Covid world.
read more
Last year, we had interviewed Paarul Oza to understand the challenges being faced by the API (active pharmaceutical ingredient) industry. Oza is the Managing Director of CRMO Pharmatech, an Indian company (headquartered in Ahmedabad) that provides complete outsourcing solutions to the pharmaceutical industry.
read more
Learn more about the challenges faced by the API (active pharmaceutical ingredient) industry in 2018, how companies are reducing dependence on China, the new regulations changing the dynamics of the API industry and the key trends for 2018.
read more
Details of draft guidance - Q11 Development and Manufacture of Drug Substances, has been undertaken.Learn more as CRMO helps to better understand this incoming guidance and what it means for the industry.
read moreGet to know more about the Indian pharmaceutical outsouring market with insights from our Managing Director, Ms Parul Oza.
read moreLearn more about CRMO methods and insights into outsourcing from India.
read moreCMRO expresses its methodology and techniques in project management for the Indian industry.
read more
